文献速递生殖医学

医学指征下冻存卵母细胞、胚胎或卵巢组织患者生育力保存结局的比较:系统综述与Meta分析

A comparison of fertility preservation outcomes in patients who froze oocytes, embryos, or ovarian tissue for medically indicated circumstances: a systematic review and meta-analysis.
PubMed 文献 · Fertil Steril · 2022-04-19

该系统综述与Meta分析检索Embase、Medline和Web of Science,纳入38项报告癌症患者冻存卵母细胞、胚胎或卵巢组织后尝试妊娠的产科结局研究。卵母细胞、胚胎和卵巢组织冻存的临床妊娠率分别为34.9%、49.0%和43.8%,活产率分别为25.8%、35.3%和32.3%,组间均无显著差异;流产率分别为9.2%、16.9%和7.5%,卵巢组织冻存流产显著少于胚胎冻存。

要点

  • 卵母细胞、胚胎和卵巢组织冻存的临床妊娠率分别为34.9%、49.0%和43.8%,组间无显著差异。
  • 活产率分别为25.8%、35.3%和32.3%,组间无显著差异。
  • 流产率分别为9.2%、16.9%和7.5%,卵巢组织冻存显著少于胚胎冻存。

核心结论

  • 该研究可为希望保存生育力的癌症患者提供咨询依据。
  • 尽管存在异质性、缺乏高质量研究和利用率低等局限性,该研究可作为性腺毒性治疗后回归家庭计划患者生殖与产科结局比较的起点。

研究设计与样本

  • 遵循PRISMA指南在Embase、Medline和Web of Science进行文献检索。
  • 纳入报告癌症患者完成卵母细胞、胚胎或卵巢组织冻存后产科结局的研究。
  • 检索获得4038条唯一条目,最终分析38项符合条件的研究。

主要发现

  • 卵母细胞、胚胎和卵巢组织冻存的临床妊娠率分别为34.9%、49.0%和43.8%,组间无显著差异。
  • 卵母细胞、胚胎和卵巢组织冻存的活产率分别为25.8%、35.3%和32.3%,组间无显著差异。
  • 卵母细胞、胚胎和卵巢组织冻存的流产率分别为9.2%、16.9%和7.5%。
  • 卵巢组织冻存的流产显著少于胚胎冻存。

关键数值与推荐

  • 临床妊娠率:卵母细胞冻存34.9%,胚胎冻存49.0%,卵巢组织冻存43.8%,组间无显著差异。
  • 活产率:卵母细胞冻存25.8%,胚胎冻存35.3%,卵巢组织冻存32.3%,组间无显著差异。
  • 流产率:卵母细胞冻存9.2%,胚胎冻存16.9%,卵巢组织冻存7.5%,卵巢组织冻存显著少于胚胎冻存。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 该研究的局限性包括异质性。
  • 该研究的局限性包括缺乏高质量研究。
  • 该研究的局限性包括利用率低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare obstetric outcomes in patients cryopreserving reproductive cells or tissues before gonadotoxic therapy. DESIGN: A literature search was conducted following PRISMA guidelines on Embase, Medline, and Web of Science. Studies reporting obstetric outcomes in cancer patients who completed cryopreservation of oocyte, embryo, or ovarian tissue were included. SETTING: Not applicable. PATIENT(S): Cancer patients attempting pregnancy using cryopreserved cells or tissues frozen before cancer therapy. INTERVENTION(S): Oocyte, embryo, or ovarian tissue cryopreservation for fertility preservation in cancer. MAIN OUTCOME MEASURE(S): The total numbers of clinical pregnancies, live births, and miscarriages in women attempting pregnancy using cryopreserved reproductive cells or tissues were calculated. A meta-analysis determined the effect size of each intervention. RESULT(S): The search returned 4,038 unique entries. Thirty-eight eligible studies were analyzed. The clinical pregnancy rates were 34.9%, 49.0%, and 43.8% for oocyte, embryo, and ovarian tissue cryopreservation, respectively. No significant differences were found among groups. The live birth rates were 25.8%, 35.3%, and 32.3% for oocyte, embryo, and ovarian tissue cryopreservation, respectively, with no significant differences among groups. The miscarriage rates were 9.2%, 16.9%, and 7.5% for oocyte, embryo, and ovarian tissue cryopreservation, respectively. Significantly fewer miscarriages occurred with ovarian tissue cryopreservation than with embryo cryopreservation. CONCLUSION(S): This enquiry is required to counsel cancer patients wishing to preserve fertility. Although the limitations of this study include heterogeneity, lack of quality studies, and low utilization rates, it serves as a starting point for comparison of reproductive and obstetric outcomes in patients returning for family-planning after gonadotoxic therapy.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Ní Dhonnabháin B, Elfaki N, Fraser K, et al. A comparison of fertility preservation outcomes in patients who froze oocytes, embryos, or ovarian tissue for medically indicated circumstances: a systematic review and meta-analysis. Fertil Steril. 2022. PMID: 35459522. doi:10.1016/j.fertnstert.2022.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。